Enzymology
COX-2 inhibition may be of use for controlling epithelial malignancy
Published in Cancer Weekly, October 14th, 2003
According to a study from the United States, "cyclooxygenase-2 (COX-2) is upregulated in a number of epithelial cancers, including in upper aerodigestive tract (UADT) premalignant and malignant lesions. The purpose of this review is to provide a comprehensive examination of the potential of COX-2 inhibition in prevention of UADT premalignant and malignant disease."
"A Medline and Cancerlit literature search was conducted for the period 1993-2002, and identified literature was reviewed," described S. Mohan and colleagues, University of Washington, Department of Oral Medicine.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-10-14)
More Articles from Cancer Weekly
- Bladder Cancer
Widespread adoption of laparoscopic cystectomy may increase death rate - Brain Cancer
Antigen targeted in melanoma therapy also prompts response in brain tumor cells - Aging
Findings in yeast may reveal why growing older is the greatest carcinogen in humans - Breast Cancer
Antisense p21 ODN triggers breast cancer cell apoptosis - Cancer Risk Factor
Obesity increases risk of some hormone-dependent tumors - Carcinoma
Nitric oxide synthase plays a role in the angiogenesis of bladder cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
